How long should you take venetoclax/venetoclax?
Venetoclax/Venetoclax is a targeted drug mainly used to treat certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and acute lymphoblastic leukemia (ALL). The length of use of venetoclax and when to stop it usually need to be decided based on the patient's condition and the doctor's advice.
In clinical practice, there is no fixed standard for the use time of venetoclax, but is adjusted based on the patient's disease progression, treatment response, side effects and other factors. Doctors may start patients on a low dose of venetoclax and gradually increase the dose no more than once a week for the first 5 weeks if the patient is being treated for CLL or SLL, or once a day for the first 3 or 4 days if the patient is being treated for AML.

Venetoclax is often given in combination with other chemotherapy drugs, and treatment cycles may last anywhere from a few months to a year or two. During treatment, doctors will regularly monitor patients' blood indicators to evaluate treatment effects and detect potential side effects. If a patient experiences significant effects after receiving venetoclax, such as tumor shrinkage or improvement in blood markers, doctors may consider continuing maintenance therapy. However, once optimal treatment effects are achieved, or if the patient experiences severe side effects, doctors may recommend discontinuing venetoclax. Additionally, in some cases, if a patient's condition is stable, doctors may choose to reduce the dose or interval of medication to reduce the risk of side effects.
Discontinuation of venetoclax is not absolute. Some patients may relapse after stopping medication, so doctors will take these risks into consideration when deciding whether to discontinue medication. If the decision is made to discontinue the medication, the doctor will usually develop a detailed follow-up plan to monitor the patient's health and disease progression.
Reference materials:https://medlineplus.gov/druginfo/meds/a616028.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)